GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Grand Brilliance Group Holdings Ltd (HKSE:08372) » Definitions » Net Cash per Share

Grand Brilliance Group Holdings (HKSE:08372) Net Cash per Share : HK$0.05 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Grand Brilliance Group Holdings Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Grand Brilliance Group Holdings's Net Cash per Share for the quarter that ended in Sep. 2023 was HK$0.05.

The historical rank and industry rank for Grand Brilliance Group Holdings's Net Cash per Share or its related term are showing as below:

HKSE:08372' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1   Med: 1.41   Max: 6.67
Current: 2.08

During the past 8 years, the highest Price-to-Net-Cash Ratio of Grand Brilliance Group Holdings was 6.67. The lowest was 1.00. And the median was 1.41.

HKSE:08372's Price-to-Net-Cash is ranked better than
83.33% of 12 companies
in the Medical Distribution industry
Industry Median: 6.73 vs HKSE:08372: 2.08

Grand Brilliance Group Holdings Net Cash per Share Historical Data

The historical data trend for Grand Brilliance Group Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Brilliance Group Holdings Net Cash per Share Chart

Grand Brilliance Group Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Cash per Share
Get a 7-Day Free Trial 0.06 0.07 0.06 0.05 0.06

Grand Brilliance Group Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 - 0.06 - 0.05

Competitive Comparison of Grand Brilliance Group Holdings's Net Cash per Share

For the Medical Distribution subindustry, Grand Brilliance Group Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Brilliance Group Holdings's Price-to-Net-Cash Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Grand Brilliance Group Holdings's Price-to-Net-Cash falls into.



Grand Brilliance Group Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Grand Brilliance Group Holdings's Net Cash per Share for the fiscal year that ended in Mar. 2023 is calculated as

Net Cash per Share (A: Mar. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(61.858-16.578-0)/800
=0.06

Grand Brilliance Group Holdings's Net Cash per Share for the quarter that ended in Sep. 2023 is calculated as

Net Cash per Share (Q: Sep. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(53.463-13.503-0.005)/800
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grand Brilliance Group Holdings  (HKSE:08372) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Grand Brilliance Group Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Grand Brilliance Group Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Brilliance Group Holdings (HKSE:08372) Business Description

Traded in Other Exchanges
N/A
Address
6 Sha Tsui Road, The Octagon, Units 2901-2903 and 2905, 29th Floor, New Territories, Tsuen Wan, Hong Kong, HKG
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. The company serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.

Grand Brilliance Group Holdings (HKSE:08372) Headlines

No Headlines